Company Filing History:
Years Active: 2021-2025
Title: **The Innovative Mind of Matthias Helmut Schmalisch**
Introduction
Matthias Helmut Schmalisch, an accomplished inventor based in South San Francisco, CA, has made significant contributions to the field of biotechnology. With a total of four patents to his name, Schmalisch is at the forefront of innovations that leverage genetically modified microorganisms for the conversion of methane and other carbon substrates into valuable chemical products.
Latest Patents
Schmalisch's latest patents showcase his expertise and pioneering spirit. One of his notable inventions involves methods and microorganisms for the fermentation of methane to multi-carbon compounds. This innovation highlights genetically modified microorganisms capable of converting methane into isobutanol, a chemical that has various industrial applications. The patent details the processes for creating these microorganisms and their applications, marking a significant advancement in chemical production.
Another remarkable patent focuses on methods and microorganisms for producing 2,3-butanediol and its derivatives from C1 carbons. In this innovation, Schmalisch outlines genetically modified methanotrophs that efficiently generate 2,3-butanediol directly from methane sources. This work not only elucidates the techniques for developing these microorganisms but also explores how they can be effectively utilized, further underscoring Schmalisch's contributions to sustainable chemical manufacturing.
Career Highlights
Currently, Matthias Helmut Schmalisch is affiliated with Precigen, Inc., a biopharmaceutical company known for its innovative approaches to product development. Schmalisch's work at Precigen emphasizes his commitment to harnessing biotechnology for practical applications that can drive industry forward. His tenure in this role reflects his focus on advancing the capabilities and efficiencies of microbial processes.
Collaborations
Throughout his career, Schmalisch has collaborated with other talented professionals, including colleagues Xinhua Zhao and Mark Anton Held. These collaborations enhance the interdisciplinary nature of his work and foster a creative environment for innovation. Together, they strive to push the boundaries of what is possible within the realm of biotechnology.
Conclusion
Matthias Helmut Schmalisch exemplifies the spirit of innovation in biotechnology with his groundbreaking work on genetically modified microorganisms. His contributions not only advance scientific knowledge but also pave the way for more sustainable industrial practices. As industries increasingly seek eco-friendly solutions, inventors like Schmalisch play a crucial role in shaping the future of chemical production. With continued dedication to his work, his future inventions are likely to make a lasting impact on the field.